Orthopedic device companies were hit by elective surgery delays and cancellations amid the pandemic in 2020.
Four of the five major companies reported double-digit sales declines last year. Here is the breakdown of 2020 net sales by company:
1. Stryker: $14.4 billion (3.6 percent drop)
2. Johnson & Johnson orthopedics: $7.7 billion (12.2 percent drop)
3. Zimmer Biomet: $7 billion (12 percent drop)
4. Orthofix: $407 million (11.5 percent drop)
Smith+Nephew anticipates a 12 percent year-over-year sales drop in 2020. The company will release its annual financial report Feb. 18.
More articles on orthopedics:
11 spine device companies to watch in 2021
7 details on Zimmer Biomet's plan to spin off spine, dental
NuVasive adds to its board of directors